Drug Type Gene editing |
Synonyms dCas13X-RNA碱基编辑器(mxABE), dCas13X-derived RNA base editor |
Target |
Mechanism MYO6 modulators(myosin VI modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationRare Pediatric Disease (US), Orphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hearing Disorders | Preclinical | CN | 20 Jul 2022 | |
Hearing Disorders | Preclinical | CN | 20 Jul 2022 |